Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Messiaen, Peter ^a   de Spiegelaere, Ward ^a   Alcami, Jose ^b   Vervisch, Karen ^a   van Acker, Petra ^a   Verhasselt, Bruno ^c   Meuwissen, Pieter ^c   Calonge, Esther ^b   Gonzalez, Nuria ^b   Gutierrez Rodero, Felix ^d   Rodriguez Martín, Carmen ^e   Sermijn, Erica ^a   Poppe, Bruce ^a   Vogelaers, Dirk ^a   Verhofstede, Chris ^c   Vandekerckhove, Linos ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c GHENT UNIVERSITY   (Belgium)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e CENTRO SANITARIO SANDOVAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LENS EPITHELIUM DERIVED GROWTH FACTOR; MESSENGER RNA;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DNA FLANKING REGION; FEMALE; GENETIC CODE; GENETIC CONSERVATION; GENETIC VARIABILITY; HAPLOTYPE MAP; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRON; MAJOR CLINICAL STUDY; MALE; NEGRO; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UNIVERSITY HOSPITAL;

3' UNTRANSLATED REGIONS; ADULT; AMINO ACID SEQUENCE; CONSERVED SEQUENCE; DISEASE PROGRESSION; EXONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRONS; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84870605230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050204     Document Type: Article

References (58)

1. Joint United Nations Programme on HIV/AIDS (2010) Global report: UNAIDS report on the global AIDS epidemic 2010. Accessible at http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf. Accessed 16/09/2012. Geneva.
2. Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293-299.
3. Arts EJ, Hazuda DJ, (2012) HIV-1 Antiretroviral Drug Therapy. Cold Spring Harbor perspectives in medicine 2 (4):: a007161.
4. Vandekerckhove L, Verhofstede C, Vogelaers D, (2009) Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients. The Journal of antimicrobial chemotherapy 63: 1087-1096.
5. Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, et al. (2004) Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells. J Virol 78: 2277-2287.
6. Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, et al. (2011) Host factors mediating HIV-1 replication. Virus research 161: 101-114.
7. Busschots K, Voet A, De Maeyer M, Rain JC, Emiliani S, et al. (2007) Identification of the LEDGF/p75 binding site in HIV-1 integrase. J Mol Biol 365: 1480-1492.
8. Cherepanov P, (2007) LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res 35: 113-124.
9. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, et al. (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278: 372-381.
10. Gijsbers R, Ronen K, Vets S, Malani N, De Rijck J, et al. (2010) LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18: 552-560.
11. Hombrouck A, De Rijck J, Hendrix J, Vandekerckhove L, Voet A, et al. (2007) Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog 3: e47.
12. Llano M, Delgado S, Vanegas M, Poeschla EM, (2004) Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 279: 55570-55577.
13. Llano M, Vanegas M, Hutchins N, Thompson D, Delgado S, et al. (2006) Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J Mol Biol 360: 760-773.
14. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, et al. (2003) LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278: 33528-33539.
15. Brown-Bryan TA, Leoh LS, Ganapathy V, Pacheco FJ, Mediavilla-Varela M, et al. (2008) Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75. Mol Cancer Res 6: 1293-1307.
16. Cohen B, Addadi Y, Sapoznik S, Meir G, Kalchenko V, et al. (2009) Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia 11: 921-933.
17. Dietz F, Franken S, Yoshida K, Nakamura H, Kappler J, et al. (2002) The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem J 366: 491-500.
18. Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, et al. (2009) Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 8: 68.
19. Sharma P, Singh DP, Fatma N, Chylack LT Jr, Shinohara T, (2000) Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 276: 1320-1324.
20. Shinohara T, Singh DP, Fatma N, (2002) LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21: 341-358.
21. Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, et al. (2007) LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer 6: 31.
22. Leoh LS, van Heertum B, De Rijck J, Filippova M, Rios-Colon L, et al. (2012) The Stress Oncoprotein LEDGF/p75 Interacts with the Methyl CpG Binding Protein MeCP2 and Influences Its Transcriptional Activity. Molecular cancer research 10: 378-391.
23. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, et al. (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nature medicine 11: 1287-1289.
24. De Rijck J, Vandekerckhove L, Gijsbers R, Hombrouck A, Hendrix J, et al. (2006) Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol 80: 11498-11509.
25. Emiliani S, Mousnier A, Busschots K, Maroun M, Van Maele B, et al. (2005) Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem 280: 25517-25523.
26. Engelman A, Cherepanov P, (2008) The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS pathogens 4: e1000046.
27. Vandekerckhove L, Christ F, Van Maele B, De Rijck J, Gijsbers R, et al. (2006) Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J Virol 80: 1886-1896.
28. Christ F, Voet A, Marchand A, Nicolet S, Desimmie BA, et al. (2010) Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat Chem Biol 6: 442-448.
29. Schrijvers R, De Rijck J, Demeulemeester J, Adachi N, Vets S, et al. (2012) LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs. PLoS Pathog 8: e1002558.
30. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
31. Fellay J, (2009) Host genetics influences on HIV type-1 disease. Antivir Ther 14: 731-738.
32. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791.
33. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
34. Telenti A, Ioannidis JP, (2006) Susceptibility to HIV infection-disentangling host genetics and host behavior. J Infect Dis 193: 4-6.
35. Tozzi V, (2010) Pharmacogenetics of antiretrovirals. Antiviral research 85: 190-200.
36. Ballana E, Gonzalo E, Grau E, Iribarren JA, Clotet B, et al. (2012) Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individuals. AIDS 26: 527-528.
37. Madlala P, Gijsbers R, Christ F, Hombrouck A, Werner L, et al. (2011) Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression. AIDS 25: 1711-1719.
38. Garcia-Merino I, de Las Cuevas N, Jimenez JL, Gallego J, Gomez C, et al. (2009) The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 6: 27.
39. Casado C, Colombo S, Rauch A, Martinez R, Gunthard HF, et al. (2010) Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5: e11079.
40. Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, et al. (2009) Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS 23: 1163-1169.
41. Hunt PW, (2009) Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes. J Infect Dis 200: 1636-1638.
42. Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, et al. (2009) Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis 200: 1714-1723.
43. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, et al. (2008) Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197: 563-571.
44. De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K, (2008) Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms. Clin Chem 54: 982-989.
45. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ, (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49: 853-860.
46. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nature methods 7: 248-249.
47. Kumar P, Henikoff S, Ng PC, (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols 4: 1073-1081.
48. Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, et al. (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Human mutation 23: 67-76.
49. Reese MG, Eeckman FH, Kulp D, Haussler D, (1997) Improved splice site detection in Genie. Journal of computational biology 4: 311-323.
50. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, et al. (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26: 2069-2070.
51. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
52. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
53. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J, (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
54. Ensembl Project. Available: http://www.ensembl.org/Homo_sapiens/Transcript/ProtVariations?db=coreg=ENSG00000164985r=9:15464064-15511017t=ENST00000380738 Accessed 06/09/2012.
55. dbSNP Short Genetic Variations. Availabe: http://www.ncbi.nlm.nih.gov/projects/SNP/ Accessed 06/09/2012.
56. HapMap project. Available: http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap28_B36/?name=Sequence:NM_033222 Accessed 06/09/2012.
57. Veloso S, Olona M, Garcia F, Domingo P, Alonso-Villaverde C, et al. (2010) Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards. BMC Med Genet 11: 63.
58. Vandegraaff N, Devroe E, Turlure F, Silver PA, Engelman A, (2006) Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 346: 415-426.